Patients should be advised before taking this medicine if they are pregnant or breast-feeding, may be pregnant or are planning to have a baby.
Pregnancy: Due to the possible risk of birth defects, female patients of childbearing potential should take contraceptive measures before and during treatment with carboplatin.
Breast-feeding: It is not known whether carboplatin is excreted into the breast milk. Therefore, during treatment with Carboplatin Infusion, breast-feeding should be discontinued.
Fertility: Men treated with this medicine are advised not to father a child during, and up to 6 months after treatment. Advice on conservation of sperm should be sought prior to treatment because of the possibility of irreversible infertility. Treatment with carboplatin may temporarily or permanently reduce fertility in men and women.